India Globalization Capital Competitors and Similar CompaniesClear all

India Globalization Capital's competitors and similar companies include Hemogenyx Pharmaceuticals and Sollis Therapeutics.

	India Globalization Capital India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.	Hemogenyx Pharmaceuticals Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company.	Sollis Therapeutics Sollis Therapeutics is a pharmaceutical company developing non-steroid, non-opioid solutions to treat pain conditions.
Founding Date	Founding Date 2005	Founding Date 2013	Founding Date 2017
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy
Locations	Locations Bethesda, US HQ	Locations London, GB HQ	Locations Columbus, US HQ Hilliard, US
Employees	Employees 50150% increase	Employees 16	Employees 283% decrease
Valuation ($)	Valuation ($) 30 m	Valuation ($) 23.1 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $869k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $572k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $297k (FY, 2025)	Gross profit £7k (FY, 2025)	Gross profit N/A
Net income	Net income ($4.1m) (FY, 2025)	Net income (£9.8m) (FY, 2025)	Net income N/A